Plain-English translation of NCT06403943 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing two traditional Chinese medicine pills — BaiDiZiYin Pill and ShenQiYiFei Pill — to see if they help newly diagnosed tuberculosis patients when used together with standard anti-tuberculosis medications. The trial will measure whether this medication combination helps reduce symptoms like fever, cough, and night sweats, and whether it speeds up recovery and reduces side effects from chemotherapy.
Standard tuberculosis treatment is effective but can cause difficult side effects and patients may experience lingering symptoms. This trial explores whether adding this medication could help patients feel better faster and potentially protect them from some of the harsh effects of standard chemotherapy.
You likely qualify if…
You likely don't qualify if…
If you are in the treatment group, you would take 45 pills of BaiDiZiYin Pill each morning and 45 pills of ShenQiYiFei Pill each night, while also taking your standard anti-tuberculosis medications as prescribed. The control group receives only standard anti-tuberculosis treatment. The intensive treatment phase lasts 8 weeks, and researchers will monitor your symptom improvement, how quickly your sputum becomes negative (a sign of recovery), and any side effects you experience.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China